Micregen are very proud to announce that Prof. Paolo De Coppi, one of our Founding Scientists and Clinical Consultant, has been included as a global leading innovator in TIME Magazine inaugural TIME100 Health list recognising the 100 most influential individuals in health.

Recent research carried out by Prof. De Coppi and his colleagues utilises stem cells to grow ‘Mini Organs’ (Organoids). This innovative approach has the potential to advance prenatal care and treatment options for congenital malformations, particularly for conditions like undeveloped lungs in newborns, where current treatment methods are limited.

Paolo’s recognition underscores the transformative potential of stem cells. Innovative stem cell therapies hold great prospects in promoting health and enhancing the quality of active life in both adults and children.

Micregen intend to use these organoids to test the efficacy of stem cell therapies produced from its award-winning Secretomix® Platform technology.

We would like to congratulate Paolo on this remarkable achievement and look forward to sharing more success stories in the future!

You may read more HERE